MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 4521-4530 Newer>
The Motley Fool
November 19, 2004
Selena Maranjian
Should Microsoft Copy Google? Distributing a lavish dividend may not serve shareholders as well as spending the money on research and development would. mark for My Articles 122 similar articles
The Motley Fool
November 19, 2004
Rick Aristotle Munarriz
Disney's Not Goofy The entertainment giant wraps up a successful fiscal year and sets the course for consistent growth. mark for My Articles 708 similar articles
InternetNews
November 18, 2004
Clint Boulton
Oracle to PeopleSoft: It's Your Best Deal In an open letter, Oracle calls its offer for applications rival PeopleSoft in shareholders' best interest. mark for My Articles 1011 similar articles
The Motley Fool
November 18, 2004
W.D. Crotty
Is Mad Cow Disease Back? Beef export markets will likely remain closed due to another possible case of mad cow disease, putting pressure on Tyson Foods and other beef-sensitive stocks. mark for My Articles 247 similar articles
The Motley Fool
November 18, 2004
Phil Wohl
Williams-Sonoma Warily Pessimistic The specialty retailer's uncertainty about the fourth quarter is unsettling. mark for My Articles 146 similar articles
The Motley Fool
November 18, 2004
W.D. Crotty
Brown Shoe Sings the Blues The shoe retailer announces a disappointing quarter and reduces full-year guidance. mark for My Articles 165 similar articles
The Motley Fool
November 18, 2004
W.D. Crotty
Medtronic Down, Not Out Internal defibrillator maker's earnings growth rate is slowing down, but its future looks healthy. mark for My Articles 266 similar articles
The Motley Fool
November 18, 2004
Marko Djuranovic
Brookstone Rolls On The specialty retailer met analyst estimates and has raised guidance for the all-important Christmas quarter. mark for My Articles 66 similar articles
The Motley Fool
November 18, 2004
Lawrence Meyers
Sympathy for Pfizer The market acts like Vioxx, Bextra, and Celebrex are the same drugs. They're not. Investors should change direction. mark for My Articles 249 similar articles
The Motley Fool
November 18, 2004
Bill Mann
Brady's Signs Are Positive The manufacturing company's exceptionally strong results for the quarter came not just from operational improvements and a key acquisition, but also from economic tailwinds in Asia and in the U.S. mark for My Articles 11 similar articles
<Older 4521-4530 Newer>    Return to current articles.